Alzheimer's Disease as a Membrane-Associated Enzymopathy of β-Amyloid Precursor Protein (APP) Secretases

Lipids and Cellular Membranes in Amyloid Diseases

Volumn , Issue , 2011, Pages 177-194

  Hata, Saori ^a   Saito, Yuhki ^a   Suzuki, Toshiharu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Alcadein processing; Alzheimer's disease; Amyloid ; Amyloid precursor protein; Intra membrane cleaving enzyme; Secretases

Indexed keywords

EID: 84874972275     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527634323.ch8     Document Type: Chapter

References (64)

1. Alzheimer, A., Stelzmann, R.A., Schnitzlein, H.N., and Murtagh, F.R. (1995) An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". Clin. Anat., 8 (6), 429-431.
2. Perry, G., Avila, J., Kinoshita, J., and Smith, M.A. (eds.) (2006) Alzheimer's Disease; a Century of Scientific and Clinical Research, IOS Press, Amsterdam.
3. Goedert, M. and Spillantini, M.G. (2006) A century of Alzheimer's disease. Science, 314 (5800), 777-781.
4. Shankar, G.M., Li, S., Methta, T.H., Garcia-Munoz, A., Shepardson, N.E., Smith, I., Brett, F.M., Farrell, M.A., Rowan, M.J., Lemere, C.A., Regan, C.M., Walsh, D.M., Sabatini, B.L., and Selkoe, D.J. (2008) Amyloid-β protein dimers isolated directly from Alzheimer's brain impair synaptic plasticity and memory. Nat. Med., 14 (8), 837-842.
5. Suzuki, T. and Nakaya, T. (2008) Regulation of amyloid β-protein precursor by phosphorylation and protein interactions. J. Biol. Chem., 283 (44), 29633-29637.
6. Citron, M., Oltesdorf, T., Haass, C., McConlogue, L., Hung, A.Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D.J. (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer's disease β-protein production. Nature, 360 (6405), 672-674.
7. Bergmans, B.A. and De Strooper, B. (2010) Gamma-secretases: from cell biology to therapeutic strategies. Lancet Neurol., 9 (2), 215-226.
8. Thinakaran, G. and Koo, E. (2008) Amyloid precursor protein trafficking, processing, and function. J. Biol. Chem., 283 (44), 29615-29619.
9. Araki, Y., Miyagi, N., Kato, N., Yoshida, T., Wada, S., Nishimura, M., Komano, H., Yamamoto, T., De Strooper, B., Yamamoto, K., and Suzuki, T. (2004) Coordinated metabolism of alcadein and amyloid β-protein precursor regulates FE65-dependent gene transactivation. J. Biol. Chem., 279 (23), 24343-24354.
10. Hata, S., Fujishige, S., Araki, Y., Kato, N., Araseki, M., Nishimura, M., Hartmann, D., Saftig, P., Fahrenholz, F., Taniguchi, M., Urakami, K., Akatsu, H., Martins, R.N., Yamamoto, K., Maeda, M., Yamamoto, T., Nakaya, T., Gandy, S., and Suzuki, T. (2009) Alcadein cleavages by APP α-and γ-secretases generate small peptides p3-Alcs indicating Alzheimer disease-related γ-secretase dysfunction. J. Biol. Chem., 284 (152), 36024-36033.
11. Dietschy, J.M. and Turley, S.D. (2004) Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid. Res., 45 (8), 1375-1397.
12. Martins, J.I., Berger, T., Sharman, J.M., Verdile, G., Fuller, J.S., and Martins, N.R. (2009) Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. J. Neurochem., 111 (6), 1275-1308.
13. Puglielli, L., Tanzi, R.E., and Kovacs, D.M. (2003) Alzheimer's disease: the cholesterol connection. Nat. Neurosci., 6 (4), 345-351.
14. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., and Pericak Vance, M.A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261 (5123), 921-923.
15. Bu, G. (2009) Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat. Rev. Neurosci., 10 (5), 333-344.
16. Kang, D.E., Pietrzik, C.U., Baum, L., Chevallier, N., Merriam, D.E., Kounnas, M.Z., Wagner, S.L., Troncoso, J.C., Kawas, C.H., Katzman, R., and Koo, E.H. (2000) Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J. Clin. Invest., 106 (9), 1159-1166.
17. Kang, D.E., Saitoh, T., Chen, X., Xia, Y., Masliah, E., Hansen, L.A., Thomas, R.G., Thal, L.J., and Katzman, R. (1997) Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology, 49, 56-61.
18. Andersen, M.O. and Willnow, E.T. (2006) Lipoprotein receptors in Alzheimer's disease. Trends Neurosci., 29 (12), 687-694.
19. Offe, K., Dodson, S.E., Shoemaker, J.T., Fritz, J.J., Gearing, M., Levey, A.I., and Lah, J.J. (2006) The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J. Neurosci., 26 (5), 1596-1603.
20. Bu, G. and Marzolo, M. (2009) Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease. Semin. Cell Dev. Biol., 20 (2), 191-200.
21. Hancock, J.F. (2006) Lipid rafts: contentious only from simplistic standpoints. Nat. Rev. Mol. Cell. Biol., 7 (6), 456-462.
22. Brown, D.A. and London, E. (1998) Functions of lipid rafts in biological membranes. Annu. Rev. Cell. Dev. Biol., 14, 111-136.
23. Brugger, B., Sandhoff, R., Wegehingel, S., Gorgas, K., Malsam, J., Helms, J.B., Lehmann, W.D., Nickel, W., and Wieland, F.T. (2000) Evidence for segregation of sphingomyelin and cholesterol during formation of COPI-coated vesicles. J. Cell. Biol., 151 (3), 507-518.
24. Mukherjee, S. and Maxfield, F.R. (2000) Role of membrane organization and membrane domains in endocytic lipid trafficking. Traffic, 1 (3), 203-211.
25. Helms, J.B. and Zurzolo, C. (2004) Lipids as targeting signals: lipid rafts and intracellular trafficking. Traffic, 5 (4), 247-254.
26. Cordy, J.M., Hussain, I., Dingwall, C., Hooper, N.M., and Turner, A.J. (2003) Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition upregulates beta-site processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. USA, 100 (20), 11735-11740.
27. Ehehalt, R., Keller, P., Haass, C., Thiele, C., and Simons, K. (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell. Biol., 160 (1), 113-123.
28. Kalvodova, L., Kahya, N., Schwille, P., Ehehalt, R., Verkade, P., Drechsel, D., and Simons, K. (2005) Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J. Biol. Chem., 280 (44), 36815-36823.
29. Melkonian, K.A., Ostermeyer, A.G., Chen, J.Z., Roth, M.G., and Brown, D.A. (1999) Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J. Biol. Chem., 274 (6), 3910-3917.
30. Benjannet, S., Elagoz, A., Wickham, L., Mamarbachi, M., Munzer, J.S., Basak, A., Lazure, C., Cromlish, J.A., Sisodia, S., Checler, F., Chretien, M., and Seidah, N.G. (2001) Post-translational processing of beta-secretase (betaamyloid-converting enzyme) and its ectodomain shedding. The pro-and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J. Biol. Chem., 276 (14), 10879-10887.
31. Vetrivel, K.S., Meckler, X., Chen, Y., Nguyen, P.D., Seidah, N.G., Vassar, R., Wong, P.C., Fukata, M., Kounnas, M.Z., and Thinakaran, G. (2009) Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts. J. Biol. Chem., 284 (6), 3793-3803.
32. Miller, C.C., McLoughlin, D.M., Lau, K.F., Tennant, M.E., and Rogelj, B. (2006) The X11 proteins, Abeta production and Alzheimer's disease. Trends Neurosci., 29 (5), 280-285.
33. Tomita, S., Ozaki, T., Taru, H., Oguchi, S., Takeda, S., Yagi, Y., Sakiyama, S., Kirino, Y., and Suzuki, T. (1999) Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein. J. Biol. Chem., 274 (4), 2243-2254.
34. Araki, Y., Tomita, S., Yamaguchi, H., Miyagi, N., Sumioka, A., Kirino, Y., and Suzuki, T. (2003) Novel cadherin-related membrane proteins, alcadeins, enhance the X11-like protein-mediated stabilization of amyloid beta-protein precursor metabolism. J. Biol. Chem., 278 (49), 49448-49458.
35. Taru, H. and Suzuki, T. (2009) Regulation of the physiological function and metabolism of AβPP by AβPP binding proteins. J. Alzheimers Dis., 18 (2), 253-265.
36. Sano, Y., Syuzo Takabatake, A., Nakaya, T., Saito, Y., Tomita, S., Itohara, S., and Suzuki, T. (2006) Enhanced amyloidogenic metabolism of the amyloid beta-protein precursor in the X11Ldeficient mouse brain. J. Biol. Chem., 281 (49), 37853-37860.
37. Lee, J.H., Lau, K.F., Perkinton, M.S., Standen, C.L., Shemilt, S.J., Mercken, L., Cooper, J.D., McLoughlin, D.M., and Miller, C.C. (2003) The neuronal adaptor protein X11alpha reduces Abeta levels in the brains of Alzheimer's APPswe Tg2576 transgenic mice. J. Biol. Chem., 278 (47), 47025-47029.
38. Lee, J.H., Lau, K.F., Perkinton, M.S., Standen, C.L., Rogelj, B., Falinska, A., McLoughlin, D.M., and Miller, C.C. (2004) The neuronal adaptor protein X11beta reduces amyloid beta-protein levels and amyloid plaque formation in the brains of transgenic mice. J. Biol. Chem., 279 (47), 49099-49104.
39. Saito, Y., Sano, Y., Vassar, R., Gandy, S., Nakaya, T., Yamamoto, T., and Suzuki, T. (2008) X11 proteins regulate the translocation of amyloid beta-protein precursor (APP) into detergent-resistant membrane and suppress the amyloidogenic cleavage of APP by betasite-cleaving enzyme in brain. J. Biol. Chem., 283 (51), 35763-35771.
40. Sakurai, T., Kaneko, K., Okuno, M., Wada, K., Kashiyama, T., Shimizu, H., Akagi, T., Hashikawa, T., and Nukina, N. (2008) Membrane microdomain switching: a regulatory mechanism of amyloid precursor protein processing. J. Cell. Biol., 183 (2), 339-352.
41. Cruts, M. and Brouwers, N. Alzheimer Disease and Frontotemporal Dementia Mutation Database, http://www.molgen.ua.ac.be/ADMutations/.
42. Beel, A.J. and Sanders, C.R. (2008) Substrate specificity of gamma-secretase and other intramembrane proteases. Cell. Mol. Life Sci., 65 (9), 1311-1334.
43. Struhl, G. and Adachi, A. (2000) Requirements for presenilin-dependent cleavage of notch and other transmembrane proteins. Mol. Cell, 6 (3), 625-636.
44. Takasugi, N., Tomita, T., Hayashi, I., Tsuruoka, M., Niimura, M., Takahashi, Y., Thinakaran, G., and Iwatsubo, T. (2003) The role of presenilin cofactors in the gamma-secretase complex. Nature, 422 (6930), 438-441.
45. Shah, S., Lee, S.F., Tabuchi, K., Hao, Y.H., Yu, C., LaPlant, Q., Ball, H., Dann, C.E. III, Sudhof, T., and Yu, G. (2005) Nicastrin functions as a gamma-secretase-substrate receptor. Cell, 122 (3), 435-447.
46. Jick, H., Zornberg, G.L., Jick, S.S., Seshadri, S., and Drachman, D.A. (2000) Statins and the risk of dementia. Lancet, 356 (9242), 1627-1631.
47. Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G.G., and Siegel, G. (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol., 57 (10), 1439-1443.
48. Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C.G., and Simons, K. (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. USA, 95 (11), 6460-6464.
49. Fassbender, K., Simons, M., Bergmann, C., Stroick, M., Lutjohann, D., Keller, P., Runz, H., Kuhl, S., Bertsch, T., von Bergmann, K., Hennerici, M., Beyreuther, K., and Hartmann, T. (2001) Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. USA, 98 (10), 5856-5861.
50. Kojro, E., Gimpl, G., Lammich, S., Marz, W., and Fahrenholz, F. (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc. Natl. Acad. Sci. USA, 98 (10), 5815-5820.
51. Refolo, L.M., Pappolla, M.A., LaFrancois, J., Malester, B., Schmidt, S.D., Thomas-Bryant, T., Tint, G.S., Wang, R., Mercken, M., Petanceska, S.S., and Duff, K.E. (2001) A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis., 8 (5), 890-899.
52. Refolo, L.M., Malester, B., LaFrancois, J., Bryant-Thomas, T., Wang, R., Tint, G.S., Sambamurti, K., Duff, K., and Pappolla, M.A. (2000) Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis., 7 (4), 321-331.
53. Lee, S.J., Liyanage, U., Bickel, P.E., Xia, W., Lansbury, P.T. Jr., and Kosik, K.S. (1998) A detergent-insoluble membrane compartment contains A beta in vivo. Nat. Med., 4 (6), 730-734.
54. Parkin, E.T., Hussain, I., Karran, E.H., Turner, A.J., and Hooper, N.M. (1999) Characterization of detergent-insoluble complexes containing the familial Alzheimer's disease-associated presenilins. J. Neurochem., 72 (4), 1534-1543.
55. Urano, Y., Hayashi, I., Isoo, N., Reid, P.C., Shibasaki, Y., Noguchi, N., Tomita, T., Iwatsubo, T., Hamakubo, T., and Kodama, T. (2005) Association of active gamma-secretase complex with lipid rafts. J. Lipid Res., 46 (5), 904-912.
56. Wahrle, S., Das, P., Nyborg, A.C., McLendon, C., Shoji, M., Kawarabayashi, T., Younkin, L.H., Younkin, S.G., and Golde, T.E. (2002) Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol. Dis., 9 (1), 11-23.
57. Hur, J.Y., Welander, H., Behbahani, H., Aoki, M., Franberg, J., Winblad, B., Frykman, S., and Tjernberg, L.O. (2008) Active gamma-secretase is localized to detergent-resistant membranes in human brain. FEBS J., 275 (6), 1174-1187.
58. Vetrivel, K.S., Cheng, H., Kim, S.H., Chen, Y., Barnes, N.Y., Parent, A.T., Sisodia, S.S., and Thinakaran, G. (2005) Spatial segregation of gamma-secretase and substrates in distinct membrane domains. J. Biol. Chem., 280 (27), 25892-25900.
59. Vogt, L., Schrimpf, S.P., Meskenaite, V., Frischknecht, R., Kinter, J., Leone, D.P., Ziegler, U., and Sonderegger, P. (2001) Calsyntenin-1, a proteolytically processed postsynaptic membrane protein with a cytoplasmic calcium-binding domain. Mol. Cell. Neurosci., 17 (1), 151-166.
60. Araki, Y., Miyagi, N., Kato, N., Yoshida, T., Wada, S., Nishimura, M., Komano, H., Yamamoto, T., De Strooper, B., Yamamoto, K., and Suzuki, T. (2007) The novel cargo alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport. EMBO J., 26 (6), 1475-1486.
61. Papassotiropoulos, A., Stephan, D.A., Huentelman, M.J., Hoerndli, F.J., Craig, D.W., Pearson, J.V., Huynh, K.D., Brunner, F., Corneveaux, J., Osborne, D., Wollmer, M.A., Aerni, A., Coluccia, D., Hanggi, J., Mondadori, C.R., Buchmann, A., Reiman, E.M., Caselli, R.J., Henke, K., and de Quervain, D.J. (2006) Common Kibra alleles are associated with human memory performance. Science, 314 (5798), 475-478.
62. Preuschhof, C., Heekeren, H.R., Li, S.C., Sander, T., Lindenberger, U., and Backman, L. (2010) KIBRA and CLSTN2 polymorphisms exert interactive effects on human episodic memory. Neuropsychologia, 48 (2), 402-408.
63. Cole, S.L. and Vassar, R. (2008) The role Main_Text of amyloid precursor protein processing by BACE1, the β-secretase, in Alzheimer disease pathophysiology. J. Biol. Chem., 283 (4), 29621-29625.
64. Hata, S., Fujishige, S., Araki, Y., Taniguchi, M., Urakami, K., Peskind E., Akatsu, H., Araseki, M., Yamamoto, K., Martins, N. R., Maeda, M., Nishimura, M., Levey, A., Chung, K. A., Montine, T., Leverenz, J., Fagan, A., Goate, A., Bateman, R., Holtzman, D. M., Yamamoto, T., Nakaya, T., Gandy, S. and Suzuki, T. [2011] Alternative γ-secretase processing of gsecretase substrates in common forms of mild cognitive impairment and Alzheimer disease: Evidence for γ-secretase dysfunction. Annal Neurol. in press (Accepted manuscript online: 1 DEC 2010 03:29PM EST | DOI: 10.1002/ana.22343).